Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha

作者: Joachim Lupberger , François H.T. Duong , Isabel Fofana , Laetitia Zona , Fei Xiao

DOI: 10.1002/HEP.26404

关键词:

摘要: Interferon-alpha (IFN-alpha) exhibits its antiviral activity through signal transducer and activator of transcription protein (STAT) signaling the expression IFN response genes (IRGs). Viral infection has been shown to result in activation epidermal growth factor receptor (EGFR)-a host cell entry used by several viruses, including hepatitis C virus. However, effect EGFR for cellular responses is unknown. Here, we uncover cross-talk between IFN-alpha that a therapeutic on IFN-alpha-based therapies functional relevance viral evasion resistance. We show combining with inhibitor, erlotinib, potentiates each compound highly synergistic manner. The extent synergy correlated reduced STAT3 phosphorylation presence whereas STAT1 was not affected. Furthermore, enhanced suppressors cytokine 3 (SOCS3) erlotinib IRGs, radical S-adenosyl methionine domain containing 2 myxovirus resistance 1. Moreover, stimulation dimerization, but phosphorylation, indicating acts STATs at level binding DNA. Conclusions: Our results support model where inhibition impairs leading IRG activity. These data novel role open new avenues improving efficacy therapies.

参考文章(55)
Boceprevir for chronic HCV genotype 1 infection. The New England Journal of Medicine. ,vol. 365, pp. 176- 178 ,(2011) , 10.1056/NEJMC1105515
Alpna R Limaye, Roniel Cabrera, Peter V Draganov, Boceprevir for chronic HCV genotype 1 infection. The New England Journal of Medicine. ,vol. 365, ,(2011) , 10.1056/NEJMC1105515#SA1
Susan Ruff-Jamison, James E. Darnell, Zhong Zhong, Zilong Wen, Katherine Chen, Stanley W. Cohen, Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver. Journal of Biological Chemistry. ,vol. 269, pp. 21933- 21935 ,(1994) , 10.1016/S0021-9258(17)31735-0
J Pavlovic, T Zürcher, O Haller, P Staeheli, Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. Journal of Virology. ,vol. 64, pp. 3370- 3375 ,(1990) , 10.1128/JVI.64.7.3370-3375.1990
Karla J. Helbig, Daryl T.-Y. Lau, Ljiljana Semendric, Hugh A. J. Harley, Michael R. Beard, Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. ,vol. 42, pp. 702- 710 ,(2005) , 10.1002/HEP.20844
Sandra Bühler, Ralf Bartenschlager, New targets for antiviral therapy of chronic hepatitis C. Liver International. ,vol. 32, pp. 9- 16 ,(2012) , 10.1111/J.1478-3231.2011.02701.X
Natalie J. Wood, Hepatitis C: Host receptor tyrosine kinases mediate HCV entry and are a promising new target for antiviral therapy. Nature Reviews Gastroenterology & Hepatology. ,vol. 8, pp. 361- 361 ,(2011) , 10.1038/NRGASTRO.2011.89
Hao H. Ho, Lionel B. Ivashkiv, Role of STAT3 in Type I Interferon Responses NEGATIVE REGULATION OF STAT1-DEPENDENT INFLAMMATORY GENE ACTIVATION Journal of Biological Chemistry. ,vol. 281, pp. 14111- 14118 ,(2006) , 10.1074/JBC.M511797200
Hashem B. El-Serag, Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma Gastroenterology. ,vol. 142, pp. 1264- 1273.e1 ,(2012) , 10.1053/J.GASTRO.2011.12.061